LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 3.89 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,946,000 | +17.8% | 16,027 | +2.7% | 0.03% | +13.3% |
| Q1 2017 | $1,652,000 | +8.8% | 15,607 | +4.4% | 0.03% | 0.0% |
| Q4 2016 | $1,519,000 | +5.6% | 14,947 | +6.0% | 0.03% | +11.1% |
| Q3 2016 | $1,439,000 | +23.7% | 14,099 | +44.5% | 0.03% | +17.4% |
| Q2 2016 | $1,163,000 | +21.8% | 9,755 | +9.4% | 0.02% | +21.1% |
| Q1 2016 | $955,000 | – | 8,916 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |